Skip to main content
. Author manuscript; available in PMC: 2012 Jul 10.
Published in final edited form as: Clin Cancer Res. 2007 Aug 28;13(17):5195–5201. doi: 10.1158/1078-0432.CCR-07-1002

Table 2. Survival of F98 glioma-bearing rats after carboplatin chemotherapy.

Carboplatin was delivered by CED on day 13 after tumor inoculation for groups 2, 3 and 4; and on day 8 for group 5. A survival time of 200 days was considered as the endpoint of the study. Rats still alive at 200 days after inoculation of 103 F98 glioma cells were euthanized.

Group N* Carboplatin CED treatment (dose/volume) Survival time (days)
% Increased life span
Range Mean ± SE Median Mean Median
1 7 Untreated 22–34 29 ± 2 30 - -
2 10 20 μg/20 μl 32–120 55 ± 8 45 90 63
3 7 40 μg/40 μl 16–59 37 ± 6 32 26 7
4 6 100 μg/20 μl 16–52 29 ± 5 26 0 −13
5 8 40 μg/40 μl (at day 8) 27–200§ 64 ± 22 (biased) 33 120 (biased) 10
*

N is the number of animals per group.

§

One rat was still alive at day 200.

SE is the standard error of the mean.